CTOs on the Move


 
At Abaxis our mission is to supply point of care blood analyzers to the medical market and the veterinarian market. Abaxis provides leading edge technology, tools and services that support best medical practices, enabling physicians and veterinarians to respond to the health needs of their clients at the point of care while operating economical and profitable practices. Abaxis is headquartered in northern California, USA, and conducts operations around the world.
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million
  • www.abaxis.com
  • 3240 Whipple Road
    Union City, CA USA 94587
  • Phone: 510.675.6500

Executives

Name Title Contact Details

Similar Companies

MoleSafe

MoleSafe is a Millburn, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Knoxville Dermatopahtolgy Lab

Knoxville Dermatopahtolgy Lab is a Knoxville, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Precision Measurements and Instrument Corp

Precision Measurements and Instrument Corp is a Corvallis, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Agendia USA

Agendia is a precision oncology company headquartered in Irvine, California, committed to bringing patients with early stage breast cancer and their physicians the information they need to make the best decisions for the full treatment journey. The company currently offers two commercially-available genomic profiling tests, supported by the highest levels of clinical and real world evidence, that provide comprehensive genomic information that can be used to identify the most effective breast cancer treatment possible for each patient. MammaPrint®, the 70-gene breast cancer recurrence assay, is the only FDA-cleared risk of recurrence test backed by peer-reviewed, prospective outcome data and inclusion in both national and international treatment guidelines. BluePrint®, the 80-gene molecular subtyping assay, is the only commercially-available test that evaluates the underlying biology of a tumor to determine what is driving its growth. Together, MammaPrint® and BluePrint® provide a comprehensive genomic profile to help physicians make more informed decisions in the pre- and post-operative treatment settings. Agendia develops evidence-based novel genomic tests and forges partnerships with groundbreaking companies to develop next-generation digital treatment tools. The ongoing research builds an arsenal of data that improve patient outcomes and support the evolving clinical needs of patients with breast cancer and their physicians every step of the way, from initial diagnosis to cancer-free.

Oregon Medical Laboratories

Oregon Medical Laboratories is committed to using information technology to do business securely and conveniently. Our Web browser-based system, OMLnet, is designed to do just that: simplifying test orders and results retrieval. This facilitates a